Literature DB >> 28277253

Use of dexmedetomidine to treat delirium primarily caused by cannabis.

Jerrold B Leikin1, Olga Amusina2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28277253     DOI: 10.1016/j.ajem.2016.10.027

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


× No keyword cloud information.
  2 in total

1.  Dexmedetomidine for Treatment of Delayed Peak Symptoms of Cannabis Withdrawal Syndrome: A Case Report.

Authors:  Katie MacCamy; Daniel Hu
Journal:  Hosp Pharm       Date:  2020-05-13

2.  The Role of Dexmedetomidine in Pediatric Patients Presenting with an Anticholinergic Toxidrome.

Authors:  Mitchell Zekhtser; Erin Carroll; Molly Boyd; Shashikanth Ambati
Journal:  Case Rep Crit Care       Date:  2021-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.